Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF Study -

被引：37

作者：

Yoshimura, Sohei ^{[1
,8
,9
]}

Koga, Masatoshi ^{[1
]}

Sato, Shoichiro ^{[1
]}

Todo, Kenichi ^{[3
]}

Yamagami, Hiroshi ^{[2
]}

Kumamoto, Masaya ^{[1
]}

Itabashi, Ryo ^{[4
]}

Terasaki, Tadashi ^{[5
]}

Kimura, Kazumi ^{[6
]}

Yagita, Yoshiki ^{[7
]}

Shiokawa, Yoshiaki

Kamiyama, Kenji ^{[10
]}

Okuda, Satoshi ^{[11
]}

Okada, Yasushi ^{[12
]}

Takizawa, Shunya ^{[13
]}

Hasegawa, Yasuhiro ^{[14
]}

Kameda, Tomoaki ^{[15
]}

Shibuya, Satoshi ^{[16
]}

Nagakane, Yoshinari ^{[17
]}

Ito, Yasuhiro ^{[18
]}

Matsuoka, Hideki ^{[19
]}

Takamatsu, Kazuhiro ^{[20
]}

Nishiyama, Kazutoshi ^{[21
]}

Fujita, Kyohei ^{[1
]}

Kamimura, Teppei ^{[2
]}

Ando, Daisuke ^{[1
]}

Ide, Toshihiro ^{[1
]}

Yoshimoto, Takeshi ^{[2
]}

Shiozawa, Masayuki ^{[1
]}

Matsubara, Soichiro ^{[1
]}

Yamaguchi, Yoshitaka ^{[1
]}

Kinoshita, Naoto ^{[2
]}

Matsuki, Takayuki ^{[1
]}

Takasugi, Junji ^{[2
]}

Tokunaga, Keisuke ^{[1
]}

Higashida, Kyoko ^{[2
]}

Homma, Kazunari ^{[13
]}

Kario, Kazuomi ^{[15
]}

Arihiro, Shoji ^{[1
]}

Toyoda, Kazunori ^{[1
]}

机构：

[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan

[2] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan

[3] Kobe City Med Ctr Gen Hosp, Dept Neurol, Kobe, Hyogo, Japan

[4] Kohnan Hosp, Dept Stroke Neurol, Sendai, Miyagi, Japan

[5] Japanese Red Cross Kumamoto Hosp, Dept Neurol, Kumamoto, Japan

[6] Nippon Med Coll Hosp, Grad Sch Med, Dept Neurol Sci, Tokyo, Japan

[7] Kawasaki Med Sch, Dept Stroke Med, Kurashiki, Okayama, Japan

[8] Kyorin Univ, Dept Neurosurg, Sch Med, Mitaka, Tokyo, Japan

[9] Kyorin Univ, Stroke Ctr, Sch Med, Mitaka, Tokyo, Japan

[10] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan

[11] NHO Nagoya Med Ctr, Dept Neurol, Nagoya, Aichi, Japan

[12] NHO Kyushu Med Ctr, Dept Neurol & Cerebrovasc Med, Fukuoka, Japan

[13] Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa, Japan

[14] St Marianna Univ, Dept Neurol, Sch Med, Kawasaki, Kanagawa, Japan

[15] Jichi Med Univ, Sch Med, Div Neurol, Shimotsuke, Japan

[16] South Miyagi Med Ctr, Dept Neurol, Ogawara, Japan

[17] Kyoto Second Red Cross Hosp, Dept Neurol, Kyoto, Japan

[18] TOYOTA Mem Hosp, Dept Neurol, Toyota, Japan

[19] NHO Kagoshima Med Ctr, Dept Cerebrovasc Med, Kagoshima, Japan

[20] Ohta Mem Hosp, Dept Neurol, Fukuyama, Hiroshima, Japan

[21] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa, Japan

来源：

CIRCULATION JOURNAL | 2018年 / 82卷 / 07期

关键词：

Acute stroke; Atrial fibrillation; Direct oral anticoagulants; Intracranial hemorrhage; Warfarin; JAPANESE PATIENTS; WARFARIN; RISK; DABIGATRAN; METAANALYSIS; MORTALITY;

D O I：

10.1253/circj.CJ-18-0067

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: We determined the 2-year long-term risk-benefit profile in patients with stroke or transient ischemic attack (TIA) receiving warfarin or direct oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF) using a prospective, multicenter, observational registry in Japan. Methods and Results: NVAF patients within 7 days after onset of ischemic stroke/TIA were enrolled in 18 stroke centers. Outcome measures included ischemic and bleeding events and death in the 2-year follow-up period. We enrolled 1,116 patients taking either warfarin (650 patients) or DOACs (466 patients) at acute hospital discharge. DOAC users were younger and had lower National Institutes of Health Stroke Scale, CHADS(2) and discharge modified Rankin Scale scores than warfarin users (P<0.0001 each). Incidences of stroke/systemic embolism (adjusted hazard ratio, 1.07; 95% CI, 0.66-1.72), all ischemic events (1.13; 0.72-1.75), and ischemic stroke/TIA (1.58; 0.95-2.62) were similar between groups. Risks of intracranial hemorrhage (0.32; 0.09-0.97) and death (0.41; 0.26-0.63) were significantly lower for DOAC users. Infection was the leading cause of death, accounting for 40% of deaths among warfarin users. Conclusions: Stroke/TIA patients receiving DOACs for secondary prevention were younger and had lower stroke severity and risk indices than those receiving warfarin. Estimated cumulative incidences of stroke and systemic embolism within 2 years were similar between warfarin and DOACs users, but those of death and intracranial hemorrhage were significantly lower among DOAC users.

引用

页码：1935 / +

页数：10

共 50 条

[31] Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
Chang, Po-Yin
Wang, Wei-Ting
Wu, Wei-Lun
Chang, Hui-Chin
Chen, Chen-Huan
Tsai, Yi-Wen
Chiou, Shih-Hwa
Lip, Gregory Y. H.
Cheng, Hao-Min
Chiang, Chern-En
THROMBOSIS AND HAEMOSTASIS, 2022, 122 (06) : 939 - 950
[32] Timing of Anticoagulation after Acute Ischemic Stroke in Patients with Atrial Fibrillation
Alrohimi, Anas
Jickling, Glen
Buck, Brian
Butcher, Ken S.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (04) : 503 - 514
[33] Evaluation of anticoagulation in patients with atrial fibrillation admitted with acute ischemic stroke
Carlone, Brian
LaRose, Elizabeth
Bierlein, Joleen
Rolfe, Stephen
Zemrak, Wesley
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 606 - 606
[34] Prior Anticoagulation and Short- or Long-Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial Fibrillation
Tokunaga, Keisuke
Koga, Masatoshi
Itabashi, Ryo
Yamagami, Hiroshi
Todo, Kenichi
Yoshimura, Sohei
Kimura, Kazumi
Sato, Shoichiro
Terasaki, Tadashi
Inoue, Manabu
Shiokawa, Yoshiaki
Takagi, Masahito
Kamiyama, Kenji
Tanaka, Kanta
Takizawa, Shunya
Shiozawa, Masayuki
Okuda, Satoshi
Okada, Yasushi
Kameda, Tomoaki
Nagakane, Yoshinari
Hasegawa, Yasuhiro
Shibuya, Satoshi
Ito, Yasuhiro
Matsuoka, Hideki
Takamatsu, Kazuhiro
Nishiyama, Kazutoshi
Kario, Kazuomi
Yagita, Yoshiki
Fujita, Kyohei
Ando, Daisuke
Kumamoto, Masaya
Arihiro, Shoji
Toyoda, Kazunori
Takasugi, Junji
Higashida, Kyoko
Sakamoto, Yuki
Hirano, Teruyuki
Suzuki, Rieko
Nakagawara, Jyoji
Homma, Kazunari
Tanaka, Eijirou
Akiyama, Hisanao
Mochizuki, Hiroshi
Nakashima, Takahiro
Shibazaki, Kensaku
Furui, Eisuke
Maeda, Koichiro
Endo, Kaoru
Miyagi, Tetsuya
Osaki, Masato
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (03):
[35] Contemporary Trends In Oral Anticoagulation Utilization After Acute Ischemic Stroke With Atrial Fibrillation: The Treatment Disparities In Stroke And Atrial Fibrillation Study
Sur, Nicole B.
Ying, Hao
Asdaghi, Negar
Gardener, Hannah
Zhou, Lili
Gutierrez, Carolina M.
Sacco, Ralph L.
Romano, Jose G.
Rundek, Tatjana
STROKE, 2023, 54
[36] Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation
Dakay, Katarina
Chang, Andrew D.
Hemendinger, Morgan
Cutting, Shawna
McTaggart, Ryan A.
Jayaraman, Mahesh V.
Chu, Antony
Panda, Nikhil
Song, Christopher
Merkler, Alexander
Gialdini, Gino
Kummer, Benjamin
Lerario, Michael P.
Kamel, Hooman
Elkind, Mitchell S. V.
Furie, Karen L.
Yaghi, Shadi
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (01): : 192 - 197
[37] IMPACT OF LONG-TERM ANTICOAGULATION ON ISCHEMIC STROKE OUTCOMES IN ATRIAL FIBRILLATION
Abraham, Moises
Martinez, Vasquez
Quintero-Martinez, Juan Andres
Batlle, Juan C.
Vasquez, Samuel D.
Luna, Jose Antonio
Amezquita, Alvarez
Iskander, Mina
Mustafa, Mohammed
Romeo, Francisco Jose
Sancassani, Rhea B.
Goldberger, Jeffrey J.
Mitrani, Raul D.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 202 - 202
[38] Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation
Zhou, Lue
Li, Yapeng
Yang, Xin
Gu, Hongqiu
Duan, Yanran
Fu, Hang
Wang, Anran
Liu, Kai
Gao, Yuan
Song, Bo
Li, Yusheng
Jiang, Yingyu
Zhang, Jing
Wang, Chunjuan
Wang, Meng
Li, Zixiao
Xu, Yuming
Wang, Chengzeng
Wang, Yongjun
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 385 : 62 - 70
[39] The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation
Kato, Yuji
Hayashi, Takeshi
Tanahashi, Norio
Takao, Masaki
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (06): : 1490 - 1496
[40] Anticoagulation in Patients with Acute Ischemic Stroke and Atrial Fibrillation—a Balance of Risks and Benefits
Abhimanyu Beri
Sujeeth Reddy Punnam
Cardiovascular Drugs and Therapy, 2008, 22 : 419 - 425

← 1 2 3 4 5 →